Founded to advance regenerative medicine, Personalized Stem Cells focuses on providing FDA-approved, autologous adipose-derived stem cell services for clinical trials. Their core mission is to facilitate access to innovative stem cell therapies, enabling physicians to offer cutting-edge treatments for conditions like arthritis. The company offers services such as StemInsure®, a personalized stem cell banking solution, allowing individuals to store their younger stem cells for future medical use.
Notable affiliated individuals include experienced medical professionals and researchers dedicated to advancing stem cell applications. The company has secured significant investments from key players in the biotech industry, bolstering its research and development efforts. Personalized Stem Cells has achieved FDA approval for its clinical trials, marking a significant milestone in the field of regenerative medicine. Their impact lies in pioneering accessible, personalized treatment options that hold promise for a range of medical conditions.